MTAP and breast cancer: Cytotoxicity assays with inhibitors of de novo adenine synthesis, 5-fluorouracil (5-FU), methotrexate (MTX) and 5′aza-deoxycytidine (AZA) after MTAP gene knockdown in breast cancer cell lines have shown an increased sensitivity to 5-FU [4].